Search research articles
Contact Us
Filters
Showing results (91-100 of 105) with videos related to
Page
of 11
Sort By:
Clinical Pharmacology and Therapeutics
|
November 14, 1997
Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drug-drug interaction
L D Lewis, A Benin, C L Szumlanski, et al.
American Journal of Veterinary Research
|
December 1, 1991
Effects of dietary fiber supplementation on glycemic control in dogs with alloxan-induced diabetes mellitus
R W Nelson, S L Ihle, L D Lewis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 11, 1999
Escalating multiple-dose safety and tolerance study of oral WR 6026 in HIV-infected subjects: AIDS clinical trials group 173
B G Petty, J R Black, C W Hendrix, et al.
Journal of Hematotherapy
|
October 1, 1995
Clinical trials of bispecific antibody MDX-210 in women with advanced breast or ovarian cancer that overexpresses HER-2/neu
F H Valone, P A Kaufman, P M Guyre, et al.
Clinical Pharmacology and Therapeutics
|
January 12, 2017
A Pharmacokinetic and Safety Study of Trebananib, an Fc-Fusion Peptibody, in Patients With Advanced Solid Tumors and Varying Degrees of Renal Dysfunction
B Wu, L D Lewis, R D Harvey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1995
Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu
F H Valone, P A Kaufman, P M Guyre, et al.
Journal of Veterinary Internal Medicine
|
December 26, 2006
Phase I and pharmacokinetic evaluation of the combination of orally administered docetaxel and cyclosporin A in tumor-bearing cats
M C McEntee, K M Rassnick, D B Bailey, et al.
Archives of Biochemistry and Biophysics
|
July 24, 1998
Induction of cytochrome P4503A by taxol in primary cultures of human hepatocytes
V E Kostrubsky, L D Lewis, S C Strom, et al.
Journal of Immunological Methods
|
February 27, 2001
Pharmacokinetic-pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: a multiple-dose phase-I study in patients with advanced cancer which overexpresses HER-2/neu
L D Lewis, B F Cole, P K Wallace, et al.
Leukemia
|
August 24, 2007
Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity
R Humeniuk, L G Menon, P J Mishra, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 105) with videos related to
Sort By:
Page
of 11
Clinical Pharmacology and Therapeutics
|
November 14, 1997
Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drug-drug interaction
L D Lewis, A Benin, C L Szumlanski, et al.
American Journal of Veterinary Research
|
December 1, 1991
Effects of dietary fiber supplementation on glycemic control in dogs with alloxan-induced diabetes mellitus
R W Nelson, S L Ihle, L D Lewis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 11, 1999
Escalating multiple-dose safety and tolerance study of oral WR 6026 in HIV-infected subjects: AIDS clinical trials group 173
B G Petty, J R Black, C W Hendrix, et al.
Journal of Hematotherapy
|
October 1, 1995
Clinical trials of bispecific antibody MDX-210 in women with advanced breast or ovarian cancer that overexpresses HER-2/neu
F H Valone, P A Kaufman, P M Guyre, et al.
Clinical Pharmacology and Therapeutics
|
January 12, 2017
A Pharmacokinetic and Safety Study of Trebananib, an Fc-Fusion Peptibody, in Patients With Advanced Solid Tumors and Varying Degrees of Renal Dysfunction
B Wu, L D Lewis, R D Harvey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1995
Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu
F H Valone, P A Kaufman, P M Guyre, et al.
Journal of Veterinary Internal Medicine
|
December 26, 2006
Phase I and pharmacokinetic evaluation of the combination of orally administered docetaxel and cyclosporin A in tumor-bearing cats
M C McEntee, K M Rassnick, D B Bailey, et al.
Archives of Biochemistry and Biophysics
|
July 24, 1998
Induction of cytochrome P4503A by taxol in primary cultures of human hepatocytes
V E Kostrubsky, L D Lewis, S C Strom, et al.
Journal of Immunological Methods
|
February 27, 2001
Pharmacokinetic-pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: a multiple-dose phase-I study in patients with advanced cancer which overexpresses HER-2/neu
L D Lewis, B F Cole, P K Wallace, et al.
Leukemia
|
August 24, 2007
Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity
R Humeniuk, L G Menon, P J Mishra, et al.
Page
of 11